New Approaches in the Design of Targeted Nanocarriers for Drug Delivery
American Journal of Pharmaceutics · 2024-10-31 · 5 (5) · 36-51
DOI: 10.71465/ajph2730 ↗At a glance
Journal article in American Journal of Pharmaceutics, published online on 2024-10-31. Written by Dr. Emily Stone. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Targeted drug delivery systems using nanocarriers have emerged as a promising strategy for enhancing the therapeutic efficacy and minimizing side effects of conventional treatments. This article discusses the latest advancements in the design of nanocarriers, focusing on their potential to deliver drugs precisely to the desired sites, thus improving the pharmacokinetics and therapeutic outcomes. The paper reviews various strategies, including ligand-receptor mediated targeting, stimuli-responsive nanocarriers, and the use of multifunctional nanoparticles. Furthermore, challenges in clinical translation and future directions in nanocarrier design are also discussed.
Cite
APA
Stone, D. E. (2024). New Approaches in the Design of Targeted Nanocarriers for Drug Delivery. American Journal of Pharmaceutics, 5(5), 36-51. https://doi.org/10.71465/ajph2730
Vancouver
Stone DE. New Approaches in the Design of Targeted Nanocarriers for Drug Delivery. American Journal of Pharmaceutics. 2024;5(5):36-51. doi:10.71465/ajph2730
BibTeX
@article{Stone2024,
author = {Stone, Dr. Emily},
title = {New Approaches in the Design of Targeted Nanocarriers for Drug Delivery},
journal = {American Journal of Pharmaceutics},
year = {2024},
volume = {5},
number = {5},
pages = {36--51},
doi = {10.71465/ajph2730}
}
EUVIMED